ZNF665
gene geneOn this page
Also known as FLJ14345ZFP160L
Summary
ZNF665 (zinc finger protein 665, HGNC:25885) is a protein-coding gene on chromosome 19q13.42, encoding Zinc finger protein 665 (Q9H7R5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 79788 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 127 total
- MANE Select transcript:
NM_024733
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25885 |
| Approved symbol | ZNF665 |
| Name | zinc finger protein 665 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14345, ZFP160L |
| Ensembl gene | ENSG00000197497 |
| Ensembl biotype | protein_coding |
| Entrez | 79788 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 7 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000396424, ENST00000596373, ENST00000596564, ENST00000597544, ENST00000598440, ENST00000600412, ENST00000650736, ENST00000868912, ENST00000868913, ENST00000958707, ENST00000958708
RefSeq mRNA: 4 — MANE Select: NM_024733
NM_001353457, NM_001353458, NM_001353459, NM_024733
CCDS: CCDS46169
Canonical transcript exons
ENST00000396424 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002522516 | 53175445 | 53175571 |
| ENSE00003097857 | 53162424 | 53166347 |
| ENSE00003131003 | 53193312 | 53193358 |
| ENSE00003572815 | 53182884 | 53182943 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 93.34.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.1438 / max 54.2742, expressed in 1239 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182555 | 3.1438 | 1239 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 93.34 | gold quality |
| buccal mucosa cell | CL:0002336 | 93.30 | gold quality |
| caput epididymis | UBERON:0004358 | 93.24 | gold quality |
| cauda epididymis | UBERON:0004360 | 92.84 | gold quality |
| medial globus pallidus | UBERON:0002477 | 90.98 | gold quality |
| globus pallidus | UBERON:0001875 | 89.20 | gold quality |
| pancreatic ductal cell | CL:0002079 | 89.07 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 88.80 | silver quality |
| postcentral gyrus | UBERON:0002581 | 88.20 | gold quality |
| cartilage tissue | UBERON:0002418 | 88.07 | silver quality |
| superficial temporal artery | UBERON:0001614 | 87.66 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.30 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 87.07 | silver quality |
| parietal lobe | UBERON:0001872 | 86.49 | gold quality |
| olfactory bulb | UBERON:0002264 | 86.23 | gold quality |
| adult organism | UBERON:0007023 | 86.15 | gold quality |
| myocardium | UBERON:0002349 | 86.02 | silver quality |
| heart right ventricle | UBERON:0002080 | 86.00 | silver quality |
| diaphragm | UBERON:0001103 | 85.94 | silver quality |
| oocyte | CL:0000023 | 85.86 | gold quality |
| type B pancreatic cell | CL:0000169 | 85.72 | silver quality |
| skin of hip | UBERON:0001554 | 85.70 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 85.31 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 85.30 | gold quality |
| bronchus | UBERON:0002185 | 85.10 | gold quality |
| mammary duct | UBERON:0001765 | 85.00 | gold quality |
| secondary oocyte | CL:0000655 | 84.94 | gold quality |
| mammalian vulva | UBERON:0000997 | 84.61 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 84.49 | gold quality |
| thymus | UBERON:0002370 | 84.09 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 19.58 |
| E-ANND-3 | no | 5.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting ZNF665, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-6516-3P | 99.65 | 68.57 | 1238 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-190A-5P | 99.54 | 71.45 | 933 |
| HSA-MIR-190B-5P | 99.54 | 71.40 | 925 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-4728-3P | 99.47 | 68.94 | 981 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-155-5P | 99.35 | 70.16 | 1509 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
Cross-species orthologs
32 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-154p10.3 | ENSDARG00000068366 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| mus_musculus | Zfp160 | ENSMUSG00000067942 |
| rattus_norvegicus | Zfp160 | ENSRNOG00000059492 |
| drosophila_melanogaster | Sry-delta | FBGN0003512 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | hang | FBGN0026575 |
| drosophila_melanogaster | CG3032 | FBGN0029928 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG11695 | FBGN0030316 |
| drosophila_melanogaster | CG8944 | FBGN0030680 |
| drosophila_melanogaster | CG7101 | FBGN0030963 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | CG18011 | FBGN0033491 |
| drosophila_melanogaster | CG12942 | FBGN0033569 |
| drosophila_melanogaster | CG8089 | FBGN0033993 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG10654 | FBGN0036294 |
| drosophila_melanogaster | CG6791 | FBGN0037918 |
| drosophila_melanogaster | CG17803 | FBGN0038547 |
| drosophila_melanogaster | CG12219 | FBGN0043796 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | pzg | FBGN0259785 |
| drosophila_melanogaster | mld | FBGN0263490 |
| drosophila_melanogaster | zf30C | FBGN0270924 |
| caenorhabditis_elegans | ztf-15 | WBGENE00011066 |
| caenorhabditis_elegans | WBGENE00013734 | |
| caenorhabditis_elegans | WBGENE00015649 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 665 — Q9H7R5 (reviewed: Q9H7R5)
Alternative names: Zinc finger protein 160-like
All UniProt accessions (2): A0A3Q5AD24, Q9H7R5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (4): NP_001340386, NP_001340387, NP_001340388, NP_079009* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096, PF01352
UniProt features (24 total): zinc finger region 18, sequence variant 3, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7R5-F1 | 73.10 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 48 (showing top):
GOCC_NUCLEOLUS, YOSHIMURA_MAPK8_TARGETS_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR4306, MIR513A_5P, MIR190A_5P, MIR190B_5P, MIR215_3P, MIR96_3P, GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP, GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP, GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP, GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleolus (GO:0005730), microtubule cytoskeleton (GO:0015630)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| cytoskeleton | 1 |
Protein interactions and networks
STRING
442 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF665 | KRABD2 | Q6ZNG9 | 431 |
| ZNF665 | TMEM74B | Q9NUR3 | 393 |
| ZNF665 | ARMH4 | Q86TY3 | 366 |
| ZNF665 | RSKR | Q96LW2 | 360 |
| ZNF665 | SYDE2 | Q5VT97 | 349 |
| ZNF665 | DENND4B | O75064 | 348 |
| ZNF665 | LRATD1 | Q96KN4 | 327 |
| ZNF665 | RETREG3 | Q86VR2 | 324 |
| ZNF665 | TTC36 | A6NLP5 | 323 |
| ZNF665 | DUSP18 | Q8NEJ0 | 322 |
| ZNF665 | RNF145 | Q96MT1 | 314 |
| ZNF665 | KLHL5 | Q96PQ7 | 308 |
| ZNF665 | N4BP2 | Q86UW6 | 300 |
| ZNF665 | OTOGL | Q3ZCN5 | 296 |
| ZNF665 | TPTE2 | Q6XPS3 | 287 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNF665 | pepP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): ZNF665 (Affinity Capture-MS), ZNF665 (Proximity Label-MS)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
127 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 109 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1403 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:53166344:ATATC:A | acceptor_loss | 1.0000 |
| 19:53166347:TCTG:T | acceptor_loss | 1.0000 |
| 19:53166348:C:CA | acceptor_loss | 1.0000 |
| 19:53166349:T:A | acceptor_loss | 1.0000 |
| 19:53175438:T:TA | donor_gain | 1.0000 |
| 19:53175484:C:A | donor_gain | 1.0000 |
| 19:53175567:TGTCC:T | acceptor_gain | 1.0000 |
| 19:53175570:CC:C | acceptor_gain | 1.0000 |
| 19:53175571:CC:C | acceptor_gain | 1.0000 |
| 19:53175571:CCTAA:C | acceptor_loss | 1.0000 |
| 19:53175572:C:CC | acceptor_gain | 1.0000 |
| 19:53175572:CT:C | acceptor_loss | 1.0000 |
| 19:53175573:T:G | acceptor_loss | 1.0000 |
| 19:53166343:GATAT:G | acceptor_gain | 0.9900 |
| 19:53166345:TAT:T | acceptor_gain | 0.9900 |
| 19:53166348:C:CC | acceptor_gain | 0.9900 |
| 19:53175440:CTCA:C | donor_loss | 0.9900 |
| 19:53175441:TCACC:T | donor_loss | 0.9900 |
| 19:53175442:CACCC:C | donor_loss | 0.9900 |
| 19:53175443:AC:A | donor_gain | 0.9900 |
| 19:53175444:C:CT | donor_loss | 0.9900 |
| 19:53175444:CC:C | donor_gain | 0.9900 |
| 19:53175460:T:TA | donor_gain | 0.9900 |
| 19:53175483:T:TA | donor_gain | 0.9900 |
| 19:53175568:GTCC:G | acceptor_gain | 0.9900 |
| 19:53193310:A:AC | donor_gain | 0.9900 |
| 19:53193311:C:CC | donor_gain | 0.9900 |
| 19:53193311:CG:C | donor_gain | 0.9900 |
| 19:53193311:CGCGG:C | donor_gain | 0.9900 |
| 19:53166344:ATAT:A | acceptor_gain | 0.9800 |
AlphaMissense
4518 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:53164585:G:C | F635L | 0.998 |
| 19:53164585:G:T | F635L | 0.998 |
| 19:53164587:A:G | F635L | 0.998 |
| 19:53164669:G:C | F607L | 0.998 |
| 19:53164669:G:T | F607L | 0.998 |
| 19:53164671:A:G | F607L | 0.998 |
| 19:53165173:A:C | F439L | 0.997 |
| 19:53165173:A:T | F439L | 0.997 |
| 19:53165175:A:G | F439L | 0.997 |
| 19:53165341:G:C | F383L | 0.997 |
| 19:53165341:G:T | F383L | 0.997 |
| 19:53165343:A:G | F383L | 0.997 |
| 19:53165509:A:C | F327L | 0.997 |
| 19:53165509:A:T | F327L | 0.997 |
| 19:53165511:A:G | F327L | 0.997 |
| 19:53165593:G:C | F299L | 0.997 |
| 19:53165593:G:T | F299L | 0.997 |
| 19:53165595:A:G | F299L | 0.997 |
| 19:53165677:A:C | F271L | 0.997 |
| 19:53165677:A:T | F271L | 0.997 |
| 19:53165679:A:G | F271L | 0.997 |
| 19:53164501:A:C | F663L | 0.996 |
| 19:53164501:A:T | F663L | 0.996 |
| 19:53164503:A:G | F663L | 0.996 |
| 19:53164753:A:C | F579L | 0.996 |
| 19:53164753:A:T | F579L | 0.996 |
| 19:53164755:A:G | F579L | 0.996 |
| 19:53164921:A:C | F523L | 0.996 |
| 19:53164921:A:T | F523L | 0.996 |
| 19:53164923:A:G | F523L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000268467 (19:53191708 G>A), RS1000301168 (19:53191462 T>C), RS1000315901 (19:53179561 C>T), RS1000355836 (19:53192965 G>A), RS1000477979 (19:53171184 C>G), RS1000568432 (19:53167071 G>A), RS1000599231 (19:53192819 G>A), RS1000630286 (19:53192682 A>C), RS1000647140 (19:53181025 A>G), RS1000762290 (19:53185446 G>A), RS1000824442 (19:53194462 A>G), RS1000870151 (19:53175633 C>T), RS1000893437 (19:53193181 A>G), RS1000976715 (19:53189733 A>G), RS1001050502 (19:53169072 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001508_5 | Asthma | 4.000000e-06 |
| GCST003026_6 | Yu-Zhi constitution type in type 2 diabetes | 5.000000e-06 |
| GCST006298_5 | Response to haloperidol in schizophrenia | 7.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007638 | Yu-Zhi constitution type |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation, increases mutagenesis, affects methylation, decreases expression | 4 |
| Arsenic | affects methylation, increases methylation | 2 |
| Valproic Acid | decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.